Who are Ascendis Pharma A/S's main suppliers?

Ascendis Pharma A/S (ASND) key suppliers include: VISEN-PHARMACEUTICALS, TEIJIN-LIMITED, OPKO Health, Inc.. View the full supplier network at chainsifter.com/chain/ASND.

Who are Ascendis Pharma A/S's major customers?

Ascendis Pharma A/S (ASND) key customers include: Werewolf Therapeutics, Inc., OPKO Health, Inc.. View the full customer network at chainsifter.com/chain/ASND.

What sector is Ascendis Pharma A/S in?

Ascendis Pharma A/S (ASND) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ASND Supply Chain: Ascendis Pharma A/S Supplier List & 6 Relationships

3Suppliers

2Customers

1Debt Items

20Related Chains

Ascendis Pharma A/S Suppliers

Ticker	Name	Confidence	Evidence
VISEN-PHARMACEUTICALS	VISEN-PHARMACEUTICALS	90%	In connection with the formation of VISEN, we granted VISEN exclusive rights to develop and commercialize our rare disease endocrinology products based on our proprietary TransCon technologies
TEIJIN-LIMITED	TEIJIN-LIMITED	85%	we entered into an exclusive license agreement with Teijin Limited, to develop and commercialize Tr
OPK	OPKO Health, Inc.	72%	Reciprocal relationship from OPK graph: aboratories, molecular diagnostic firms, universities and research institutions. Most of these companies have substantially greater financial and other resourc…

Ascendis Pharma A/S Customers

Ticker	Name	Confidence	Evidence
HOWL	Werewolf Therapeutics, Inc.	72%	Reciprocal relationship from HOWL graph: lines and the superior response obtained by the INDUKINE molecule format when compared to the dosing of recombinant cytokine. In April 2022, we entered into a…
OPK	OPKO Health, Inc.	72%	Reciprocal relationship from OPK graph: aboratories, molecular diagnostic firms, universities and research institutions. Most of these companies have substantially greater financial and other resourc…

Ascendis Pharma A/S Debt Obligations

Instrument	Description	Confidence	Evidence
ASND-DEBT	Debt stack $1.0B	90%	Market cache reports total debt of $1.0B.

Ascendis Pharma A/S Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ascendis Pharma A/S.

Ascendis Pharma A/S Ownership

Holder	Name	Confidence	Evidence
ASND-OWNER-RA-CAPITAL-MANAGEMENT-L-P	RA CAPITAL MANAGEMENT, L.P.	90%	13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 273 tracked holders.

Ascendis Pharma A/S Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
EDIT	Editas Medicine, Inc.	100.00	2
ATOS	Atossa Therapeutics, Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
CUE	Cue Biopharma, Inc.	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CANF	Can-Fite BioPharma Ltd.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2

Ascendis Pharma A/S Supply Chain